---
title: "Goldman Sachs Sticks to Its Buy Rating for Pharmaron Beijing Co., Ltd. Class H (17Q1)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284856975.md"
description: "Goldman Sachs has reaffirmed its Buy rating for Pharmaron Beijing Co., Ltd. Class H, setting a price target of HK$29.70. The stock closed at HK$21.72 last Tuesday. The analyst consensus for Pharmaron is a Strong Buy, with a price target consensus of €3.18."
datetime: "2026-05-01T01:05:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284856975.md)
  - [en](https://longbridge.com/en/news/284856975.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284856975.md)
---

# Goldman Sachs Sticks to Its Buy Rating for Pharmaron Beijing Co., Ltd. Class H (17Q1)

In a report released on April 29, from Goldman Sachs maintained a Buy rating on Pharmaron Beijing Co., Ltd. Class H, with a price target of HK$29.70. The company’s shares closed last Tuesday at HK$21.72.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Pharmaron Beijing Co., Ltd. Class H has an analyst consensus of Strong Buy, with a price target consensus of €3.18.

### Related Stocks

- [03759.HK](https://longbridge.com/en/quote/03759.HK.md)
- [300759.CN](https://longbridge.com/en/quote/300759.CN.md)
- [GS.US](https://longbridge.com/en/quote/GS.US.md)
- [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md)

## Related News & Research

- [Pharmaron Beijing Issues Unaudited First-Quarter 2026 Report Under Hong Kong Rules](https://longbridge.com/en/news/284364965.md)
- [BOCOM International Holdings Company Reaffirms Their Buy Rating on Pharmaron Beijing Co., Ltd. Class H (17Q1)](https://longbridge.com/en/news/281677802.md)
- [Orient Securities Keeps Their Buy Rating on Kuaishou Technology Class B (1024)](https://longbridge.com/en/news/286040131.md)
- [Kuaishou Technology Class B (1024) Receives a Buy from UBS](https://longbridge.com/en/news/286172016.md)
- [JD.com, Inc. Class A (9618) Gets a Buy from China Merchants Securities](https://longbridge.com/en/news/286363442.md)